Investigation of the Effect of Blood Pressure on Bedsores

July 9, 2026 updated by: Yavuz Uren, Yuzuncu Yil University

Investigation of the Effect of Blood Pressure on Bedsores in Adult Internal Medicine Intensive Care Patients

The aim of this study is to comprehensively investigate the effect of blood pressure levels on the development of bedsores (pressure ulcers) in adult patients hospitalized in the internal medicine intensive care unit.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

The aim of this study is to comprehensively investigate the effect of blood pressure levels on the development of bedsores (pressure ulcers) in adult patients hospitalized in the internal medicine intensive care unit. In intensive care patients, several factors, such as prolonged immobility, decreased level of consciousness, circulatory disorders, and hemodynamic instability, increase the risk of bedsore formation. This study specifically aims to evaluate the effects of systemic blood pressure changes-such as hypotension or hypertension-on skin integrity and to determine the contribution of these effects to the development of bedsores.

Study Type

Observational

Enrollment (Estimated)

148

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey (Türkiye)
      • Van, Turkey (Türkiye), 65000
        • SBU. Van Education and Research Hospital
        • Contact:
        • Principal Investigator:
          • Yavuz Uren
        • Sub-Investigator:
          • Hayrullah Şavlı
        • Sub-Investigator:
          • Gülden Atan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

SBU. Van Education and Research Hospital Internal Intensive Care Unit

Description

Inclusion Criteria:

  • Patients admitted to the intensive care unit,
  • Aged between 18-70 years,
  • Bedridden, immobile patients,
  • Patients who have signed the informed consent form themselves or through a close relative.

Exclusion Criteria:

  • Patients under 18 years of age,
  • Patients who did not give their consent for the study or whose relatives did not consent, or who wanted to leave while the study was ongoing,
  • Patients who arrived with bedsores

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intensive care patients
The development and timing of bedsores in patients will be recorded. Vital signs will also be monitored.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Decubitus Ulcer
Time Frame: For 10 days
Pressure ulcers will be assessed using the Norton Pressure Ulcer Scale Daily Rating.
For 10 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vital signs - Blood pressure measurements (SBP, DBP)
Time Frame: For 10 days
Blood pressure measurements (SBP, DBP)
For 10 days
Vital signs - heart rate
Time Frame: For 10 days
heart rate will be taken.
For 10 days
Vital signs - respiratory rate
Time Frame: For 10 days
respiratory rate per minute will be taken.
For 10 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Yuzuncu Yil University

Investigators

  • Study Chair: yavuz üren, Yuzuncu Yil University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 15, 2026

Primary Completion (Estimated)

November 20, 2026

Study Completion (Estimated)

November 20, 2026

Study Registration Dates

First Submitted

June 24, 2026

First Submitted That Met QC Criteria

July 9, 2026

First Posted (Actual)

July 10, 2026

Study Record Updates

Last Update Posted (Actual)

July 10, 2026

Last Update Submitted That Met QC Criteria

July 9, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Ulcer-HT

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Decubitus Ulcer

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe